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A 23-year-old Caucasian woman with 1 week of left-sided
headache was admitted to our hospital with six stereotyped
episodes of right-sided numbness, right-sided facial twitching,
and expressive language difﬁculty lasting for 1-2 min. Past
medical history included anxiety and a chronic (>10 years),
stable right-sided neck mass that was biopsied and revealed
only nonspeciﬁc inﬂammation with no evidence of infection or
malignancy. Brain magnetic resonance imaging (MRI) with
gadolinium performed on admission showed subtle left frontoparietal T2-ﬂuid-attenuated inversion recovery (FLAIR)
cortical hyperintensity with overlying leptomeningeal enhancement (Figure 1A and B), raising concern for focal meningoencephalitis. No abnormality was seen on T2-weighted or
diffusion-weighted imaging. Electroencephalography performed inter-ictally showed left temporal slowing without
epileptiform activity. Serologic testing for human immunodeﬁciency virus, syphilis, and anti-nuclear antibodies were negative. Computed tomography of the thorax/abdomen/pelvis and
gallium scan showed no evidence of malignancy or sarcoidosis.
Lumbar puncture on admission day 2 revealed a normal opening pressure, cerebrospinal ﬂuid (CSF) lymphocytic pleocytosis (88 nucleated cells, 74% lymphocytes), elevated protein of
433 mg/L (200-400 mg/L), normal glucose, normal CSF/serum
IgG index, and no CSF-speciﬁc oligoclonal bands. Upon
recognizing in retrospect that her clinico-radiographic presentation was typical of unilateral cortical FLAIR-hyperintense
Lesions in Anti-MOG-associated Encephalitis with Seizures
(FLAMES), testing for myelin oligodendrocyte glycoprotein
(MOG)-IgG was performed on stored CSF and was positive
(ﬁxed cell-based assay, EUROIMMUN). Comprehensive CSF
testing for other antibodies associated with encephalitis,
including N-methyl-D-aspartate receptor-IgG, was negative.
No stored serum was available for MOG-IgG testing. She was
prescribed lacosamide 100 mg PO BID without immunotherapy. One-month follow-up brain MRI showed resolution of her
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left frontoparietal abnormalities (Figure 1C and D), although a
new, enhancing lesion of the corpus callosum compatible with
demyelinating disease was seen (Figure 2). Cervicothoracic
MRI was normal. She was monitored closely. Repeat brain
MRI 8 months later was normal, and serum MOG-IgG testing 4
months and 8 months after disease presentation was negative.
Lumbar puncture for repeat CSF MOG-IgG testing was not
performed. At 12-month follow-up lacosamide was tapered off
over 4 weeks, and she remains symptom-free at 15-month
follow-up.
MOG-IgG-associated disease (MOGAD) is a subset of
inﬂammatory demyelinating disease that most commonly
presents with optic neuritis, acute disseminated encephalomyelitis, transverse myelitis, or isolated brainstem syndromes1.
Unilateral cortical FLAMES is another recently characterized
manifestation of MOGAD that is deﬁned as follows: unilateral
cortical T2-FLAIR hyperintensity without the involvement of
the adjacent juxtacortical white matter on MRI, some combination of seizures, headache, fever, and/or cortical symptoms
(e.g. aphasia) referable to the location of T2-FLAIR hyperintensity, MOG-IgG positivity by cell-based assay, and exclusion of alternative diagnoses.2 Serum MOG-IgG testing is
preferred due to generally lower clinical sensitivity (i.e. higher
false-negative rate) of CSF, although fortunately, the available
literature does not indicate lower clinical speciﬁcity (i.e. higher
false-positive rate) of CSF that would cast doubt on the
diagnosis in our patient3. Nonetheless, lack of serum MOGIgG testing at disease onset due to delayed recognition of
unilateral cortical FLAMES is a limitation to our report that
highlights the need for increased awareness of this unique
MOGAD phenotype. Disease processes that may have a similar
cortical and/or leptomeningeal neuroimaging appearance
include Creutzfeldt–Jakob disease, seizure-related change,
anti-gamma-aminobutyric acid (A) receptor encephalitis,
mitochondrial encephalopathy with lactic acidosis and
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Bilateral cortical and/or leptomeningeal involvement may uncommonly occur in MOGAD,2 suggesting that unilateral cortical FLAMES exists on a broader spectrum of MOG-IgGpositive meningoencephalitis. Patients typically respond well
to corticosteroids, although resolution without immunotherapy
similar to our case has been reported.5 Recognition of this
distinct clinico-radiographic syndrome is important for accurate diagnosis and treatment.
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Figure 1: Brain MRI in unilateral cortical FLAMES. (A) Axial T2FLAIR image shows subtle left frontal cortical hyperintensity (red circle).
(B) Axial T1-weighted post-gadolinium image shows overlying leptomeningeal enhancement (red circle). (C and D) One-month follow-up
imaging shows resolution of cortical and leptomeningeal abnormalities.
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Figure 2: Brain MRI showing corpus callosum lesion after unilateral
cortical FLAMES. (A) Sagittal T2-FLAIR image shows a small lesion of
the genu of the corpus callosum (red arrow). (B) Sagittal T1-weighted
post-gadolinium image shows lesion enhancement (red arrow).

stroke-like episodes (MELAS), stroke-like migraine attacks
after radiation therapy (SMART), reperfusion injury, subarachnoid hemorrhage, infectious and carcinomatous meningitides.4
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